In 1977, Takeda first entered the U.S. pharmaceutical market by developing a joint venture with Abbott Laboratories called TAP Pharmaceuticals.
I 1977 gik Takeda for første gang ind på det amerikanske marked med udviklingen af et joint venture med Abbott Laboratories kaldet TAP Pharmaceuticals.